You can now enjoy all six stories from our popular ANZCA Bulletin series 'Beyond City Limits' as an ebook.

The Western Australian Therapeutic Advisory Group and the Western Australian Drug Evaluation Panel have endorsed the delisting of Desflurane from the WA Statewide Medicines Formulary.

FPM committees support the board in achieving its objectives in the training, examination and continuing education of specialist pain medicine physicians and in setting the standards of clinical practice for pain medicine in Australia and New Zealand.

The 2023 edition of Australasian Anaesthesia (AKA the Blue Book) is now available.

In September 2022, we visted Darwin to talk to specialist anaesthetists, trainees, and medical students about living and working in Australia's Top End.

We’ve developing an ePortfolio for specialist international medical graduates (SIMGs).

Information about the 2024 ANZCA Council elections.

Mundipharma have advised the faculty of the discontinuation of the following products from the pain medicine portfolio:

Applications for 2024 bursaries are now open.

Updates include: PPRN webinar; Foundation supporter evening; 2024 research grants; global health challenges